Bharat Parenterals Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1002949,
    "name": "Bharat Parenter.",
    "stock_name": "Bharat Parenter.",
    "full_name": "Bharat Parenterals Ltd",
    "name_url": "stocks-analysis/bharat-parenter",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,300.05",
    "chg": -20.8,
    "chgp": "-1.57%",
    "dir": -1,
    "prev_price": "1,320.85",
    "mcapval": "943.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 541096,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE365Y01019",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": 775,
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/bharat-parenter-1002949-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Bharat Parenterals Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-bharat-parenterals-ltd-latest-results-good-or-bad-3999564",
        "imagepath": "",
        "date": "2026-05-19 19:21:30",
        "description": "Bharat Parenterals Ltd's latest financial results for Q4 FY26 reflect a company facing significant operational challenges. The consolidated net loss for the quarter stood at ₹4.80 crores, which represents a slight improvement in terms of a lower loss compared to the previous quarter. However, this figure indicates persistent difficulties in achieving profitability. \n\nNet sales for the quarter were reported at ₹99.62 crores, showing a sequential increase of 52.81% from the previous quarter, but this figure is still 4.19% lower than the same quarter last year. This revenue volatility suggests inconsistent demand and potential issues with customer retention in the pharmaceutical sector.\n\nThe operating margin, excluding other income, was negative at -0.53%, marking the lowest level in recent quarters. This reflects a significant decline from the previous year's operating margin of 11.88%, indicating severe pres..."
      },
      {
        "title": "Bharat Parenterals Ltd Falls 3.72%: 4 Key Factors Driving the Weekly Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bharat-parenterals-ltd-falls-372-4-key-factors-driving-the-weekly-momentum-shift-3983145",
        "imagepath": "",
        "date": "2026-05-09 13:00:05",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>4 May:</strong> Week opens at ₹1,259.45</p>\n                    <p><strong>5 May:</strong> Mixed technical signals amid price momentum shift</p>\n                    <p><strong>7 May:</strong> Upgrade to Sell on technical improvements despite weak fundamentals</p>\n                    <p><strong>8 May:</strong> Technical momentum shifts to mildly bearish; week closes at ₹1,212.65 (-3.72%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,259.45</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-v..."
      },
      {
        "title": "Bharat Parenterals Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bharat-parenterals-ltd-technical-momentum-shifts-amid-mixed-market-signals-3980816",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BharatParentera_technicaldot_3980816.png",
        "date": "2026-05-08 08:05:01",
        "description": "Bharat Parenterals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum from mildly bullish to mildly bearish, reflecting increased market uncertainty. The stock’s recent 5.77% decline and downgrading of its Mojo Grade from Strong Sell to Sell on 6 May 2026 underscore the evolving technical landscape and investor caution."
      },
      {
        "title": "Bharat Parenterals Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bharat-parenterals-ltd-upgraded-to-sell-on-technical-improvements-despite-weak-fundamentals-3979098",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BharatParentera_mojoScore_3979098.png",
        "date": "2026-05-07 08:31:00",
        "description": "Bharat Parenterals Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 6 May 2026, driven primarily by a shift in technical indicators despite persistent fundamental weaknesses. The pharmaceutical micro-cap’s recent price momentum and improved technical trend contrast with its flat financial performance and deteriorating profitability metrics, presenting a complex picture for investors."
      },
      {
        "title": "Bharat Parenterals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bharat-parenterals-ltd-is-rated-strong-sell-3959041",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BharatParentera_mojoScore_3959041.png",
        "date": "2026-04-23 10:10:22",
        "description": "Bharat Parenterals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 29 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Bharat Parenterals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bharat-parenterals-ltd-is-rated-strong-sell-3943465",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BharatParentera_mojoScore_3943465.png",
        "date": "2026-04-12 10:10:12",
        "description": "Bharat Parenterals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 29 September 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 12 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Bharat Parenterals Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bharat-parenterals-ltd-technical-momentum-shifts-amid-mixed-market-signals-3933779",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BharatParentera_technicaldot_3933779.png",
        "date": "2026-04-06 08:02:23",
        "description": "Bharat Parenterals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. Despite a modest day change of 0.19%, the stock’s technical indicators reveal a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators, suggesting cautious investor sentiment amid volatile price action."
      },
      {
        "title": "Bharat Parenterals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bharat-parenterals-ltd-is-rated-strong-sell-3928358",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BharatParentera_mojoScore_3928358.png",
        "date": "2026-04-01 10:10:15",
        "description": "Bharat Parenterals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 29 September 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 01 April 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Bharat Parenterals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bharat-parenterals-ltd-is-rated-strong-sell-3904961",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BharatParentera_mojoScore_3904961.png",
        "date": "2026-03-21 10:10:13",
        "description": "Bharat Parenterals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 29 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 15,
    "sid": "1002949",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/bharat-parenterals-1002949"
  },
  "announcements": [
    {
      "caption": "Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015",
      "datetime": "16-Jun-2026",
      "details": "Disclosure under regulation 7(2) of SEBI (PIT) Regulations 2015.",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "16-Jun-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Desai Shares & Stocks Pvt Ltd",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "03-Jun-2026",
      "details": "Please find the enclosed newspaper notice to the physical Shareholders informing them about the special Window for re lodge the transfer deed.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bharat Parenterals Ltd has declared <strong>10%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are Bharat Parenterals Ltd latest results good or bad?

2026-05-19 19:21:30

Bharat Parenterals Ltd's latest financial results for Q4 FY26 reflect a company facing significant operational challenges. The consolidated net loss for the quarter stood at ₹4.80 crores, which represents a slight improvement in terms of a lower loss compared to the previous quarter. However, this figure indicates persistent difficulties in achieving profitability. Net sales for the quarter were reported at ₹99.62 crores, showing a sequential increase of 52.81% from the previous quarter, but this figure is still 4.19% lower than the same quarter last year. This revenue volatility suggests inconsistent demand and potential issues with customer retention in the pharmaceutical sector. The operating margin, excluding other income, was negative at -0.53%, marking the lowest level in recent quarters. This reflects a significant decline from the previous year's operating margin of 11.88%, indicating severe pres...

Bharat Parenterals Ltd Falls 3.72%: 4 Key Factors Driving the Weekly Momentum Shift

2026-05-09 13:00:05

Key Events This Week 4 May: Week opens at ₹1,259.45 5 May: Mixed technical signals amid price momentum shift 7 May: Upgrade to Sell on technical improvements despite weak fundamentals 8 May: Technical momentum shifts to mildly bearish; week closes at ₹1,212.65 (-3.72%) Week OpenRs.1,259.45 Week Close<div class="stat-v...

Bharat Parenterals Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-05-08 08:05:01

Bharat Parenterals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum from mildly bullish to mildly bearish, reflecting increased market uncertainty. The stock’s recent 5.77% decline and downgrading of its Mojo Grade from Strong Sell to Sell on 6 May 2026 underscore the evolving technical landscape and investor caution.

Bharat Parenterals Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals

2026-05-07 08:31:00

Bharat Parenterals Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 6 May 2026, driven primarily by a shift in technical indicators despite persistent fundamental weaknesses. The pharmaceutical micro-cap’s recent price momentum and improved technical trend contrast with its flat financial performance and deteriorating profitability metrics, presenting a complex picture for investors.

Bharat Parenterals Ltd is Rated Strong Sell

2026-04-23 10:10:22

Bharat Parenterals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 29 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Bharat Parenterals Ltd is Rated Strong Sell

2026-04-12 10:10:12

Bharat Parenterals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 29 September 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 12 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook.

Bharat Parenterals Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-04-06 08:02:23

Bharat Parenterals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. Despite a modest day change of 0.19%, the stock’s technical indicators reveal a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators, suggesting cautious investor sentiment amid volatile price action.

Bharat Parenterals Ltd is Rated Strong Sell

2026-04-01 10:10:15

Bharat Parenterals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 29 September 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 01 April 2026, providing investors with the latest insights into its performance and outlook.

Bharat Parenterals Ltd is Rated Strong Sell

2026-03-21 10:10:13

Bharat Parenterals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 29 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

View All News